Carbapenems (eg, imipenem, meropenem) and the monobactam antibiotic aztreonam are generally reserved for serious infections caused by. Meropenem – Download as PDF File .pdf), Text File .txt) or read online. antibiotik Meropenem. Copyright: © All Rights Reserved. Download as PDF, TXT or. , Meropenem45, MEM, 10 mcg, 10/SP. , Metronidazole78, MET, 80 mcg, 10/SP. , Mezlocillin46, MZ, 75 mcg, 1/EA.

Author: Akikus Mugrel
Country: Vietnam
Language: English (Spanish)
Genre: Relationship
Published (Last): 16 May 2016
Pages: 103
PDF File Size: 10.69 Mb
ePub File Size: 8.87 Mb
ISBN: 900-3-67593-803-4
Downloads: 79252
Price: Free* [*Free Regsitration Required]
Uploader: Nikoramar

β-lactam antibiotic

Therefore, polymyxins may be most effective as part of a combination for serious CRE infections [ 3443 ]. Gram-negative anaerobes Bacteroides caccae Bacteroides fragilis group Prevotella bivia Prevotella disiens. Do not freeze the reconstituted solution. The following table of pathogens listed is derived from clinical experience and therapeutic guidelines.

This medicinal product contains approximately 2 mEq of sodium per mg dose which should be taken into consideration by patients on a controlled sodium diet.

Common side effects include nausea, diarrhea, constipation, headache, rash, and pain at the site of injection. Dose recommended by Garonzik et al [ 31 ] much greater than maximum approved dose, see article for more information.

EnterobacteriaceaePseudomonas aeruginosa, Acinetobacter spp. Renal meropebem adjustments are necessary for colistin and CMS but are not required polymyxin B [ 29 ]. Mainly found in Klebsiella pneumoniae have been identified in other Enterobacteriaceae and nonfermenters.

Accumulates in the intracellular and tissue compartments rapidly after IV infusion. Several cases of severe hypokalemia have been reported.

Meronem IV mg & 1g – Summary of Product Characteristics (SmPC) – (eMC)

Applied Microbiology and Biotechnology. Company contact details Pfizer Limited.


Evolution of merppenem resistance among Enterobacteriaceae focus on extended spectrum beta-lactamases and carbapenemases. There have been many reports of increases in the anti-coagulant effects of antiboitik administered anti-coagulant agents, including warfarin in patients who are concomitantly receiving antibacterial agents.

Adults and Adolescents Infection Dose to be administered every 8 hours Severe pneumonia including hospital and ventilator-associated pneumonia. Retrieved 8 December No studies on the effect on the ability to drive and meropenemm machines have been performed. In the most comprehensive review to date, which included data on patients with CRE infections, combination therapy with 2 or more in vitro active agents was associated with lower mortality than treatment with a single in vitro active agent Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp.

Meronem IV 500mg & 1g

In the first study, all patients who received combination therapy had favorable outcomes, whereas Inherently resistant organisms Gram-negative aerobes Stenotrophomonas maltophilia Legionella species.

No specific medicinal product interaction studies other than probenecid were conducted. It is expected that ceftazidime-avibactam will be available in the second quarter of High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria. Carbapenem resistance in Enterobacteriaceae: In a review of 4, patients with 5, meropenem treatment exposures, meropenem-related adverse reactions most frequently reported were diarrhoea 2.

Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections

Despite this increasing burden, the most optimal treatment for CRE infections is largely unknown. This condition frequently occurs in patients with hematological malignancies and cancer patients receiving anticancer drugs that suppress bone marrow formation. Gram-positive anaerobes except Clostridium difficile. In critically ill patients, strongly consider combination therapy.

Core Drugs Empiric Treatment: Impact of various conditions on the efficacy of dual carbapenem therapy against KPC-producing Klebsiella pneumoniae.


Line related, 12 Inhibit PG chain elongation: Support Center Merooenem Center. Detection and treatment options for Klebsiella pneumoniae carbapenemases KPCs: In a review of 20 clinical studies, the combination of an aminoglycoside and a carbapenem had the lowest mortality rate However, there are little data on the safety of higher-dose antjbiotik [ 348283 ].

Combination therapy for CRE infections may decrease mortality compared with monotherapy. Table 1 System Organ Class Frequency Event Infections and infestations Uncommon oral and vaginal candidiasis Blood and anyibiotik system disorders Common thrombocythaemia Uncommon eosinophilia, thrombocytopenia, leucopenia, neutropenia, agranulocytosis, haemolytic anaemia Immune system disorders Uncommon angioedema, anaphylaxis see sections 4.

Feb 25, Available at: Infusion For intravenous infusion meropenem vials may be directly constituted with 0. Ceftazidime-avibactam received a priority review based on Phase II data, and it should be reserved for patients with limited or no alternative treatment options [ 72 ]. Bacteraemia due to OXAcarbapenemase-producing Enterobacteriaceae: In a review which included 24 cases of aminoglycoside combination therapy most often with colistin, carbapenems, fluoroquinolones, and tigecyclineall patients who failed aminoglycoside-based combination therapy had bloodstream infections [ 68 ].

Emergence of resistance to fosfomycin used as antobiotik therapy in KPC Klebsiella pneumoniae bacteraemia: There is no target-based cross-resistance between meropenem atnibiotik agents of the quinolone, aminoglycoside, macrolide and tetracycline classes. Trends Mol Med ;